Healthy volunteers test new injection method for Infection-Fighting drug
NCT ID NCT06918587
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new way to give a drug for febrile neutropenia (a serious fever with low white blood cells) in 180 healthy adults. Researchers compared how the body absorbs the drug when given by a prefilled syringe versus an on-body injector. They also monitored safety and checked for immune reactions to the drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEBRILE NEUTROPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Al-Essra Hospital
Amman, Jordan, 11941, Jordan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pharmacist-Led lessons may cut infection risk in chemo patients
- Smart patch could spot chemo side effects before they become dangerous
- Acupuncture may cut hospital time for chemo patients
- Gut check: Antibiotics' hidden impact on transplant recovery
- Can a smart thermometer protect kids on chemo from dangerous fevers?
- Can kids with cancer stop antibiotics sooner? new trial investigates